about
Biochemical markers in carbon-tetrachloride-and galactosamine-induced acute liver injuries: the effects of dihydroquinoline-type antioxidantsHepatoprotective effect of aged black garlic extract in rodents.Chylomicrons enhance endotoxin excretion in bileInhibition of 5-lipoxygenase pathway attenuates acute liver failure by inhibiting macrophage activationClinical pathologic correlation in viral hepatitis. The effect of the virus on the liverHepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.Protective effects of Moutan Cortex Radicis against acute hepatotoxicity.Galactosamine-induced cell death in primary cultures of rat hepatocytes.Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.Potential intercellular futile cycling of carbohydrates in diabetesIsolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency.UDP-glucosamine as a substrate for dolichyl monophosphate glucosamine synthesis.Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: possible in vivo assay system for environmental carcinogens.A new medium-term bioassay system for detection of environmental carcinogens using diethylnitrosamine-initiated rat liver followed by D-galactosamine treatment and partial hepatectomy.
P2860
Q28367939-FFD7D054-D1EC-4C49-83CD-A5BCE5D4DA3EQ33554340-70E19850-FE6A-4CF1-B9CA-2C623DC8F198Q33605885-0E8753F2-4BBC-47DD-9D1B-6EE5AA009173Q33759028-DE3B839D-1BCB-4A35-B1FA-C713B340FE5BQ34086874-5212CC4E-7E3D-4EAA-AA97-A0FEAE913D97Q35352054-2CAA37BA-0A08-407A-A576-7E4D971A8D9DQ35361740-DD71B1D9-7B91-4D94-BFA0-D3504322E604Q35656995-97E14855-DD4C-4206-A916-5118B8034D14Q35863980-6A0CCD51-25C2-4A03-84F0-030A4EEE7640Q36375764-DD6BD7AA-EBD3-4C4F-BBFF-4375F4400B46Q40927565-984E7403-6F14-4D8F-9C6B-E032DD08B751Q41466867-526B4A11-9FFA-4BB8-ACD1-F3921C33FA2FQ41822657-ADAA84D7-F864-46B2-A9BC-F7D868A60D1BQ42867524-39CF3C89-5215-415A-A6AE-13BB16A4A400Q52538209-10FEFAF3-C54E-45C7-9067-04AE1FE61576Q55176466-DD387905-6B19-4D79-9884-51543A18F739
P2860
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Galactosamine induced liver injury.
@en
Galactosamine induced liver injury.
@nl
type
label
Galactosamine induced liver injury.
@en
Galactosamine induced liver injury.
@nl
prefLabel
Galactosamine induced liver injury.
@en
Galactosamine induced liver injury.
@nl
P1476
Galactosamine induced liver injury
@en
P2093
P304
P577
1972-01-01T00:00:00Z